Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Mastering the Medical Affairs Professional Role: Inside and Out
Summary
In this episode, Tom Caravela welcomes Kent Christofferson to discuss his career journey and insights into the MSL role. Kent shares his transition from academia to industry, highlighting the importance of mastering the MSL role and thinking like a Key Opinion Leader (KOL). He delves into the value proposition of MSLs, the significance of team effectiveness, and the challenges of handling multiple roles. The conversation covers compliance, technology, and future medical affairs directions, emphasizing digital engagement and the shift towards relationship-based interactions. Kent concludes with strategies for effective KOL engagement and the importance of leadership support in the evolving MSL landscape.
Kent Christopherson, Senior Director, Medical Affairs at Orchard Therapeutics discusses the art of Mastering the Medical Affairs Professional Role Internally and Externally.
Kent shares…
👉 Why MSLs need to “think like a KOL”
👉 The importance of Individual Development Plans
👉 Integrated Team Effectiveness Model- (ITEM) ref: 2006, Louise Lemieux-Charles, Wendy L McGuire
👉 Why clinical insights is the currency for MSL value internally
👉 Why it is vital to understand what KOLs motivation is in order to ensure value and meet deliverables
Medical Science Liaison, Key Opinion Leader, MSL Career Transition, Medical Affairs Strategies, Effective KOL Engagement
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
Article
Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
Article
iNIZIO